FOLLOWUS
1. Jiangxi University of Traditional Chinese Medicine,Nanchang,China
2. Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences,Beijing,China
纸质出版日期:2012,
网络出版日期:2012-9-11,
Scan for full text
Xiao, By., Mao, Sj. & Li, Xd. Variations in the composition of Fructus Evodiae after processing with Radix Glycyrrhizae extract., Chin. J. Integr. Med. 18, 782–787 (2012). https://doi.org/10.1007/s11655-012-1178-8
Bi-ying Xiao, Shu-jie Mao, Xian-duan Li. Variations in the composition of Fructus Evodiae after processing with Radix Glycyrrhizae extract[J]. Chinese Journal of Integrative Medicine, 2012,18(10):782-787.
Xiao, By., Mao, Sj. & Li, Xd. Variations in the composition of Fructus Evodiae after processing with Radix Glycyrrhizae extract., Chin. J. Integr. Med. 18, 782–787 (2012). https://doi.org/10.1007/s11655-012-1178-8 DOI:
Bi-ying Xiao, Shu-jie Mao, Xian-duan Li. Variations in the composition of Fructus Evodiae after processing with Radix Glycyrrhizae extract[J]. Chinese Journal of Integrative Medicine, 2012,18(10):782-787. DOI: 10.1007/s11655-012-1178-8.
To evaluate the changes in the concentrations of five components in Fructus Evodiae used in Chinese medicine
including evodiamine and glycyrrhizic acid
during processing of Fructus Evodiae with Radix Glycyrrhizae extract by using high performance liquid chromatography (HPLC) and to provide a scientific basis for different clinical uses of processed and unprocessed Fructus Evodiae. The concentrations of the Fructus Evodiae components in processed or unprocessed Fructus Evodiae were evaluated by HPLC using a YMC J’sphere ODS-H80 column (4.6 mm×250 mm
5 μm) with acetonitrile-water-tetrahydrofuran-acetic acid (41:59:1:0.2
v/v/v/v) as the mobile phase. The detection wavelength was 225 nm
the column temperature was 35°C
the flow rate was 1.0 mL/min
and the injection volume was 10 μL. The concentrations of the Radix Glycyrrhizae components were determined by HPLC with a Kromasil-C18 column (4.6 mm×250 mm
4 μm) and a gradient elution of acetonitrile (A) and 0.05% aqueous phosphoric acid (B) as the mobile phase. The detection wavelength was 237 nm
the column temperature was 35 °C
the flow rate was 1.0 mL/min
and the injection volume was 10 μL. The calibration curves of evodia lactone
evodiamine
rutaecarpine
liquiritin
and glycyrrhizin showed good linear relationships (r>0.99). The recoveries of evodia lactone
evodiamine
rutaecarpine
liquiritin
and glycyrrhizin were 96.59%
104.18%
101.91%
97.75%
and 97.95%
respectively. The concentrations of the components in processed Fructus Evodiae were obviously different to those in unprocessed Fructus Evodiae. The developed method is rapid and accurate. The results provide a reference for processed Fructus Evodiae and the changes that could be expected in its effects compared to unprocessed Fructus Evodiae
To evaluate the changes in the concentrations of five components in Fructus Evodiae used in Chinese medicine
including evodiamine and glycyrrhizic acid
during processing of Fructus Evodiae with Radix Glycyrrhizae extract by using high performance liquid chromatography (HPLC) and to provide a scientific basis for different clinical uses of processed and unprocessed Fructus Evodiae. The concentrations of the Fructus Evodiae components in processed or unprocessed Fructus Evodiae were evaluated by HPLC using a YMC J’sphere ODS-H80 column (4.6 mm×250 mm
5 μm) with acetonitrile-water-tetrahydrofuran-acetic acid (41:59:1:0.2
v/v/v/v) as the mobile phase. The detection wavelength was 225 nm
the column temperature was 35°C
the flow rate was 1.0 mL/min
and the injection volume was 10 μL. The concentrations of the Radix Glycyrrhizae components were determined by HPLC with a Kromasil-C18 column (4.6 mm×250 mm
4 μm) and a gradient elution of acetonitrile (A) and 0.05% aqueous phosphoric acid (B) as the mobile phase. The detection wavelength was 237 nm
the column temperature was 35 °C
the flow rate was 1.0 mL/min
and the injection volume was 10 μL. The calibration curves of evodia lactone
evodiamine
rutaecarpine
liquiritin
and glycyrrhizin showed good linear relationships (r>0.99). The recoveries of evodia lactone
evodiamine
rutaecarpine
liquiritin
and glycyrrhizin were 96.59%
104.18%
101.91%
97.75%
and 97.95%
respectively. The concentrations of the components in processed Fructus Evodiae were obviously different to those in unprocessed Fructus Evodiae. The developed method is rapid and accurate. The results provide a reference for processed Fructus Evodiae and the changes that could be expected in its effects compared to unprocessed Fructus Evodiae
Radix GlycyrrhizaeFructus EvodiaeHigh Performance Liquid Chromatography
Radix GlycyrrhizaeFructus EvodiaeHigh Performance Liquid Chromatography
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences. The data of past dynasties Chinese medical substances processing technologies. 1973:77.
National Pharma copoeia Committee. Chinese Pharmacopoeia. Part I. Beijing: Chemical Industry Press;2005:59–60.
The Bureau of Drug Administration of the Ministry of Health of the People’s Republic of China. State standard of Chinese substance processing. Beijing: People’s Medical Publish House;1988:154–155.
Huang JH. Evodia processing mechanism and the modern study. Strait Pharm J (Chin) 2007:19:67–68.
Yan CL, Zhang J, Xue GP. An overview on pharmacological effects of traditional Chinese medicine evodia. J Hebei North Univ (Chin) 2009:26:77–79.
Wang F, Su YH. Pharmacological action of Radix Glycyrrhizae and clinical application. Lishizhen Med Mater Res (Chin) 2002:13:303–304.
Zhuang LY, Chao RB. Determination of contents of evodiamine and rutecarpine of Fructus Euodiae and preparations by HPLC. Chin J Pharm Analy (Chin) 1997:17:174–176.
Niu ZR, Li XD, Gu XZ, Dai WY, Mao SJ. Concocting accessories Radix Glycyrrhizae juice preparation technology. China J Chin Mater Med (Chin) 2009:34:2051–2053.
Jin SY, Wang Q. Chinese herbal medicine research and clinical application processing. Beijing: Chemical Industry Press; 2004:377–382.
Deng XY, Li Q. Different processing methods on the pharmacological effects of evodia. Chin Tradit Patent Med (Chin) 1999:21:236–238.
Tian DH, Xie ZW. Practical dictionary of Chinese mdicine. Beijing: People’s Medical Publishing House; 2002:931–938.
He D, Liu FQ, Li HD. Study on the progress of Radix Glycyrrhizae detoxification. Centr South Pharm (Chin) 2009:7:927–931.
Tian SZ, Lai BL, Shi JH, Yang YT, Han XQ. Study on the progress of Radix Glycyrrhizae detoxification. World J Integr Tradit West Med (Chin) 2008:3:560–562.
Zhao MJ, Han DW, Ma XH, Zhao YC, Yi L, Li CM. Preventive and therapeutive effects of glycyrrhizin acid and saikosaponin on experimental cirrhosis in rat. Acta Pharm Sin (Chin) 1983:18:325–331.
0
浏览量
842
Downloads
2
CSCD
关联资源
相关文章
相关作者
相关机构